Trial Profile
The LOW-BP-VIENNA (Lowering Blood Pressure in Primary Care in Vienna) Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2017
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil/amlodipine (Primary) ; Olmesartan medoxomil/amlodipine/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms Low BP Vienna
- 20 Jun 2017 Status changed from recruiting to completed.
- 25 Jul 2014 New trial record